Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.49, $0.05 better than the analyst estimate of $0.44. Revenue for the quarter came in at $20.4 million versus the consensus estimate of $20.01 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Freedom Broker Starts Holley (HLLY) at Buy
• U.S. military says it is striking Iran over Strait of Hormuz attacks
• ​SpaceX plans to launch new AI model with Cursor - The Information